Summary
Microgravity has been implicated to play a role in the observed immune dysfunction of astronauts and cosmonauts after either short-term or long-term space travel. These reports, together with studies describing increased levels of microorganisms in the space cabin environment suggest potential risk for in-flight incidences of infectious diseases. In order to understand the mechanism underlying these immune defects, it is important to have a ground-based model that would reliably mimic the effects of microgravity on antigen-specific immune function. We tested the utility of the rotating wall vessel (RWV) technology developed at NASA as a model system because in the RWV the culture medium and the cells rotate synchronously with the vessel, thereby creating simulated microgravity conditions. We compared the RWV to the conventional tissue culture flask (T-flask), for culturing immune precursor cells with cytotoxic T lymphocyte (CTL) activity against synthetic viral peptides. We observed a significant loss of antigen-specific CTL activity in RWV cultures, but not in those from the T-flask, irrespective of the peptide immunogen used for inducing the primary immune response in different mouse strains. Loss of CTL activity in RWV cultures coincided with a significant reduction in CD8+ cells as well as CD4+ cells and DEC205+ dendritic cells, suggesting adverse effects of RWV culturing on both the effector and accessory cells for the loss of antigen-specific CTL function. These results provide a strong parallel to the reported defects in cell-mediated immunity during space travel and strongly support the utility of the RWV technology as an effective ground-based model for identifying key steps in immune cell dysfunction related to microgravity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bevan, M. J. Stimulating killer cells. Nature 342:478–479; 1989.
Casement, K. S.; Arlinghaus, R. B.; Sastry, K. J. Cytotoxic T-lymphocyte response induced by a V3 loop synthetic peptide from an African HIV-1 isolate is cross-reactive against HIV-1 strains from North America/Europe regions. AIDS 10:1440–1441; 1996.
Casement, K. S.; Nehete, P. N.; Arlinghaus, R. B., et al. Cross-reactive cytotoxic T lymphocytes induced by V3 loop synthetic peptides from different strains of human immunodeficiency virus type 1. Virology 211:261–267; 1995.
Cogoli, A. Signal transduction in T lymphocytes in microgravity. Gravit. Space Biol. Bull. 10:5–16; 1997.
Cogoli, A.; Cogoli-Greuter, M. Activation and proliferation of lymphocytes and other mammalian cells in microgravity. Adv. Space Biol. Med. 6:33–79; 1997.
Cooper, D.; Pellis, N. R. Suppressed PHA activation of T lymphocytes in simulated microgravity is restored by direct activation of protein kinase C. J. Leukoc. Biol. 63:550–562; 1998.
Gmunder, F. K.; Konstantinova, I. V.; Cogoli, A., et al. Cellular immunity in cosmonauts during spaceflight on board the orbital MIR station. Aviat. Space Environ. Med. 65:419–423; 1994.
Houghten, R. A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 87:2344–2348; 1985.
Jessup, J. M.; Goodwin, T. J.; Spaulding, G. F. Prospects for use of microgravity-based bioreactors to study three-dimensional host-tumor interactions in human neoplasia. J. Cell. Biochem. 51:290–300; 1993.
Konstantinova, I. V.; Rykova, M. P.; Lesnyak, A. T., et al. Immune changes during long-duration missions. J. Leukoc. Biol. 54:189–201; 1993.
Licato, L. L.; Grimm, E. A. Multiple interleukin-2 signaling pathways differentially regulated by microgravity. Immunopharmacology 44:273–279; 1999.
Luckacher, A. E.; Braciale, V. L.; Braciale, T. J. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814–826; 1984.
Merrifield, R. B. Solid phase peptide synthesis. J. Am. Chem. Soc. 85:2149–2154; 1963.
Nehete, P. N.; Arlinghaus, R. B.; Sastry, K. J. Use of helper T cell-inducing peptides from conserved regions in HIV-1 env in a non-covalent mixture with a CTL-inducing V3-loop peptide for in vivo induction of long-lasting systemic CTL response. Viral Immunol. 7:189–197; 1994.
Nehete, P. N.; Casement, K. S.; Arlinghaus, R. B., et al. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp120. Cell. Immunol. 160:217–223; 1995.
Sarkar, A. S.; Tortolero-Luna, G.; Nehete, P. N., et al. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16. Viral Immunol. 8:165–174; 1995.
Sastry, K. J.; Bender, B. S.; Bell, W., et al. Effects of influenza virus-specific cytotoxic T-lymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus. Vaccine 12:1281–1287; 1994.
Sastry, K. J.; Nehete, P. N.; Venkatnarayanan, S., et al. Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of gp120. Virology 188:502–509; 1992.
Sonnenfeld, G.; Mandeel, A. D.; Konstantinova, I. V., et al. Effects of space flight on levels and activity of immune cells. Aviat. Space Environ. Med. 61:648–653; 1990.
Sonnenfeld, G.; Miller, E. S. The role of cytokines in immune changes induced by spaceflight. J. Leukoc. Biol. 54:253–258; 1993.
Stewards, R. P.; Goodwin, T. J.; Wolf, D. A. Cell culture for three-dimensional modeling in rotating-wall vessels: an application in microgravity. J. Tissue Cult. Methods 14:51–58; 1992.
Taylor, G. R. Overview of spaceflight immunology studies. J. Leukoc. Biol. 54:179–188; 1993a.
Taylor, G. R. Immune changes during short-duration missions. J. Leukoc. Biol. 54:202–208; 1993b.
Taylor, G. R.; Janney, R. P. In vivo testing confirms a blunting of the human cell-mediated immune mechanisms during space flight. J. Leukoc. Biol. 51:129–132; 1992.
Taylor, G. R.; Konstantinova, I. V.; Sonnenfeld, G., et al. Changes in the immune system during and after spaceflight. Adv. Space Biol. Med. 6:1–32; 1997.
Taylor, G. R.; Neale, L. S.; Dardano, F. R. Immunological analyses of U.S. space shuttle crewmembers. Aviat. Space Environ. Med. 57:213–217; 1986.
Tsao, Y. D.; Goodwin, T. J.; Wolf, D. A., et al. Responses of gravity level variations in the NASA/JSC bioreactor system. Physiologist 35:S49-S50; 1992.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sastry, K.J., Nehete, P.N. & Savary, C.A. Impairment of antigen-specific cellular immune responses under simulated microgravity conditions. In Vitro Cell.Dev.Biol.-Animal 37, 203–208 (2001). https://doi.org/10.1007/BF02577530
Issue Date:
DOI: https://doi.org/10.1007/BF02577530